Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Weighted Average and Diluted) (2020 - 2025)

Cellebrite DI's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at $0.09 for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 7.51% to $0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.09 through Dec 2025, down 7.51% year-over-year, with the annual reading at $0.31 for FY2025, 122.96% up from the prior year.
  • EPS (Weighted Average and Diluted) came in at $0.09 for Q4 2025, down from $87778.3 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $389800.0 in Q2 2021 to a low of -$198255.6 in Q1 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is $1612.2 (2021), against an average of $39868.1.
  • Year-over-year, EPS (Weighted Average and Diluted) surged 6268.67% in 2022 and then plummeted 312.64% in 2023.
  • Cellebrite DI's EPS (Weighted Average and Diluted) stood at $0.32 in 2021, then tumbled by 88.72% to $0.04 in 2022, then plummeted by 312.64% to -$0.08 in 2023, then skyrocketed by 219.42% to $0.09 in 2024, then fell by 7.51% to $0.09 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EPS (Weighted Average and Diluted) are $0.09 (Q4 2025), $87778.3 (Q3 2025), and $129840.0 (Q2 2025).